cl 246738 has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, PL; McKinnon, KM; Ussery, MA; Wooden, SL | 1 |
| Baron, S; Coppenhaver, DH; Lucia, HL | 1 |
2 other study(ies) available for cl 246738 and Disease Models, Animal
| Article | Year |
|---|---|
Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
Topics: Acquired Immunodeficiency Syndrome; Acridines; Animals; Antibodies; Antiviral Agents; Asialoglycoproteins; Disease Models, Animal; Drug Synergism; Female; G(M1) Ganglioside; Glucans; Guanosine; Immunologic Factors; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Poly I-C; Poly U; Pyran Copolymer; Rabbits; Rauscher Virus; Specific Pathogen-Free Organisms; Viral Plaque Assay; Zidovudine | 1996 |
Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin.
Topics: Acridines; Adjuvants, Immunologic; Animals; Antiviral Agents; Arenaviridae Infections; Disease Models, Animal; Female; Guinea Pigs; Interferon Type I; Male; Precipitin Tests; Recombinant Proteins; Ribavirin; Ribonucleosides | 1989 |